Latest news
ATAGI/THANZ statement provides further guidance for the AstraZeneca vaccine and narrows contraindication
The Australian Technical Advisory Group on Immunisation (ATAGI) and the Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ) have released a joint statement on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of the COVID-19 Vaccine AstraZeneca.
A ‘remarkable’ model for the world
Since COVID-19 began, people from indigenous communities around the world have been disproportionately affected by COVID-19.
ATAGI update following weekly COVID-19 meeting – 19 May 2021
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 19 May 2021.
Vaccine Operations Centre – Weekly Operational Update – 17 May 2021
A statement from the Vaccine Operations Centre on the status of the vaccine rollout.
ATAGI update following weekly COVID-19 meeting – 12 May 2021
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 12 May 2021.
Should you take blood thinning medication before having the AstraZeneca vaccine?
Find accurate, evidence-based answers to questions about COVID-19 vaccines, including whether you should take blood thinning medication before having the AstraZeneca vaccine.
Vaccine Operations Centre – Weekly Operational Update – 10 May 2021
A statement from the Vaccine Operations Centre on the status of the vaccine rollout.
Australian Technical Advisory Group on Immunisation (ATAGI) weekly COVID-19 meeting on 4 May 2021 update
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 4 May 2021
Vaccinations now available for people 50 years and over
The next phase of Australia's COVID-19 vaccination rollout has commenced.
ATAGI update following weekly COVID-19 meeting – 28 April 2021
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 28 April 2021
Vaccine Operations Centre – Weekly Operational Update – 26 April 2021
A statement from the Vaccine Operations Centre on the status of the vaccine rollout.
ATAGI reinforce recommendations on use of COVID-19 vaccines following review of vaccine safety data and benefits
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on use of COVID-19 vaccines following review of vaccine safety data and benefits.
Response to latest ATAGI advice
A statement from Professor Paul Kelly, Australian Government Chief Medical Officer in Response to latest ATAGI advice.
National Cabinet update from the Prime Minister
The Prime Minister provides an update from today's National Cabinet meeting where the COVID-19 vaccination program was discussed. Find out more.
COVID-19 Vaccination Program – National Cabinet update on 22 April 2021
A presentation with an update on Australia's COVID-19 vaccine rollout is now available to view or download.
Joint statement on AstraZeneca COVID-19 vaccine in response to new vaccine safety concerns
Professor Brendan Murphy, Department of Health Secretary and Professor Paul Kelly, Australian Government Chief Medical Officer have released a joint statement about ATAGI's latest clinical advice on the AstraZeneca vaccine.
Joint statement on COVID-19 AstraZeneca vaccine advice from ATAGI
A joint statement from Professor Brendan Murphy, Department of Health Secretary and Professor Paul Kelly, Australian Government Chief Medical Officer.
ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on the AstraZeneca COVID-19 vaccine in response to new vaccine safety concerns.
ATAGI statement on COVID-19 vaccination and a reported case of thrombosis
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on COVID-19 vaccination and a reported case of thrombosis.
ATAGI statement for consumers on a specific clotting condition being reported after COVID-19 vaccination
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) for consumers on a specific clotting condition being reported after COVID-19 vaccination
Joint statement on AstraZeneca COVID-19 vaccine
A statement from the acting Australian Government Chief Medical Officer, Professor Michael Kidd and Head of the Therapeutic Goods Administration Adj. Professor John Skerritt
ATAGI statement for health care providers on suitability of COVID-19 vaccination in people with history of clotting conditions
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) for health care providers on suitability of COVID-19 vaccination in people with history of clotting conditions.
ATAGI statement and clinical guidance on AstraZeneca COVID-19 vaccine following European Medicines Agency (EMA) safety review
This statement from the Australian Technical Advisory Group on Immunisation (ATAGI) updates advice previous provided on 16 March. It follows the European Medicines Agency (EMA) safety review of the AstraZeneca COVID-19 vaccine.
COVID-19 vaccination appointments to be available at GP-led respiratory clinics from 19 March 2021
COVID-19 vaccination appointments will be available at GP-led respiratory clinics from 19 March 2021. Find out more.
General Practices join the COVID-19 vaccination program
Australians eligible for Phase 1b will be able to find a vaccination provider through the new national vaccination information and location service.
Date last updated: